C-reactive protein and atrial fibrillation: Insights from epidemiological and Mendelian randomization studies

Xintao Li1, Shi Peng1, Xiaoyu Wu1

  • 1Department of Cardiology, Shanghai General Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.

Insights

Elevated C-reactive protein (CRP) is linked to atrial fibrillation (AF) in observational studies. However, genetic analysis did not confirm a causal role for CRP in AF development.

Area of Science:

  • Cardiology
  • Epidemiology
  • Genetics

Background:

  • C-reactive protein (CRP) is an inflammatory marker.
  • Atrial fibrillation (AF) is a common cardiac arrhythmia.
  • The relationship between CRP and AF requires further investigation.

Purpose of the Study:

  • To investigate the association between C-reactive protein (CRP) and atrial fibrillation (AF).
  • To examine the epidemiological and genetic links between CRP and AF.
  • To assess the causal role of CRP in AF development.

Main Methods:

  • Utilized data from the Kailuan cohort (n=86,424) with baseline and follow-up CRP measurements and ECG assessments.
  • Employed Cox proportional hazards models to analyze CRP levels and AF risk.
  • Conducted a meta-analysis of nine cohort studies and performed Mendelian randomization (MR) analysis.

Main Results:

  • High baseline CRP was not significantly associated with AF risk.
  • High cumulative CRP exposure showed a significant association with increased AF risk (HR: 1.49).
  • Meta-analysis indicated a positive association between elevated CRP and incident AF (RR: 1.27), but MR analysis found no genetic link.

Conclusions:

  • Observational data suggest a positive association between elevated CRP and incident AF.
  • Mendelian randomization analysis did not support a causal effect of CRP on AF.
  • The etiological role of CRP in AF remains uncertain.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
239
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
86
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
61
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
86
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
34
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
53